Vida Health’s virtual diabetes program significantly reduces HbA1c levels by more than most diabetes medications

Accordingto this study of our our virtual diabetes program, in 4 months, participants across the risk spectrum significantly lowered their HbA1c levels.

We are excited to announce that the latest study of our virtual diabetes program has shown improvements in members’ blood glucose management. In 4 months, participants across the risk spectrum significantly lowered their HbA1c levels:

1.7-points (for those with baseline HbA1c of ≥ 8)

1.0-point (for those with baseline HbA1c of ≥7)

Research

Zimmermann G., Venkatesan A., Rawlings K., Scahill M. (2021). Improved Glycemic Control With a Digital Health Intervention in Adults With Type 2 Diabetes: Retrospective Study. JMIR Diabetes. 18/02/2021:28033

Resources